TSI Group highlights tableting and cellular health solutions at SupplySide West
TSI Group will showcase its solutions for optimizing nutraceutical tablets as well as its Hobamine ingredient for cellular health.
Photo © iStockphoto.com
TSI Group (Missoula, MT) will showcase a host of ingredients and nutraceutical solutions at the SupplySide West trade show taking place October 31, 2022, to November 4, 2022, in Las Vegas. These solutions include the company’s Optitab process for tableting applications, as well as Hobamine, an ingredient to support cellular health.
Optitab helps companies with their tableting needs. As TSI Group explains in a press release, “Some materials are hard to get into an ideal state for tableting. Most customers take whatever grades they can import and process the materials here in the U.S. With Optitab, we’re supplying the material from the source at a competitive price, then doing the handling ourselves. Our customers have exactly what they need when the materials arrive at their production facility.”
It adds: “This is a broader scope than creating tablet-grade ingredients. Maybe the powder is too fine and needs to be milled for use. Or, perhaps an ingredient needs to be coated for timed release. TSI Group then goes the extra mile by identifying ways to improve processes so materials are specifically tailored to your needs. It’s not that we’re using proprietary processes; it’s more that we’re really good at what we do because we’ve been doing this for a very long time.”
The company will also discuss Hobamine, TSI’s 2-HOBA (2-hydroxybenzylamine) ingredient for cellular health. The company calls Hobamine a “better long-term approach to cell health because it mitigates the negative impact of damaging free radicals.”
The company will present research on Hobamine on November 3 at 1:30 pm PT at the Supplier Presentation Theater (Booth 3677) at SupplySide West. TSI Group will also discuss all of its ingredients, including myHMB, PeakATP, and GlucosaGreen, and capabilities at its own Booth 5073.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
